News Image

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development

Provided By GlobeNewswire

Last update: Jun 10, 2025

Dr. Michael Vasconcelles brings more than 25 years of extensive oncology research, development and health technology expertise and corporate executive leadership to Day One

Read more at globenewswire.com

DAY ONE BIOPHARMACEUTICALS I

NASDAQ:DAWN (7/25/2025, 8:00:01 PM)

After market: 7.3 +0.07 (+0.97%)

7.23

+0.02 (+0.28%)



Find more stocks in the Stock Screener

Follow ChartMill for more